Cargando…
Vitamin D Receptor Agonists: Suitable Candidates as Novel Therapeutic Options in Autoimmune Inflammatory Myopathy
The primary aim in the treatment of autoimmune inflammatory myopathies (IMs) is to recover muscle function. The presence of immune/inflammatory cell infiltrates within muscle tissues represents the common feature of different IM subtypes, albeit a correlation between muscular damage extent and infla...
Autor principal: | Crescioli, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033351/ https://www.ncbi.nlm.nih.gov/pubmed/24895631 http://dx.doi.org/10.1155/2014/949730 |
Ejemplares similares
-
The Vitamin D Receptor Agonist BXL-01-0029 as a Potential New Pharmacological Tool for the Treatment of Inflammatory Myopathies
por: Di Luigi, Luigi, et al.
Publicado: (2013) -
Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
por: Scolletta, Sabino, et al.
Publicado: (2013) -
Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options
por: Zeng, Rachel, et al.
Publicado: (2022) -
Vitamin D Receptor Gene Polymorphisms and Haplotypes in Hungarian Patients with Idiopathic Inflammatory Myopathy
por: Bodoki, Levente, et al.
Publicado: (2015) -
Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia
por: Rovito, Daniela, et al.
Publicado: (2020)